PDCD1 and neoplasm: Representative immune checkpoint inhibitors are monoclonal antibodies that interfere with the interaction between programmed cell death 1 (PD1) and programmed death-ligand 1 (PDL1) inhibitory proteins expressed on the surface of T cells and tumor cells, respectively [2, 3].